Sign In
Buy ACAD
$25.50
-0.720 (-2.75%)
At Close: Jul 13, 2026
Dublin, April 17, 2020 -- The "Neurodegenerative Disorder Therapeutics Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering..
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Vascular Biogenics (VBLT)
03:11am, Friday, 17'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB) and Vascular Biogenics (VBLT) with bullish
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Vascular Biogenics (NASDAQ: VBLT)
03:11am, Friday, 17'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB
's Top Upgrades, Downgrades For April 16, 2020
01:34pm, Thursday, 16'th Apr 2020
Upgrades
Raymond James upgraded the stock for Ares Capital Corp (NASDAQ: ARCC) from Market Perform to Outperform. For the fourth quarter, Ares Capital had an EPS of...
Stocks closed down on Wednesday as the economic numbers are starting to show just how weak the economy is becoming, but a drop in jobless claims (to 5.25 million) has allowed stocks to rise less than
Jefferies cuts view on Tilray in premarket analyst action
11:05am, Thursday, 16'th Apr 2020
ACADIA Pharmaceuticals (NASDAQ:ACAD) initiated with a Buy rating and a $60 (33% upside) price target at Jefferies.eHealth (NASDAQ:EHTH) initiated with an Overweight rating and a $150 (26% upside) pric
Jefferies Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces Price Target to $60
12:00am, Thursday, 16'th Apr 2020Madrigal Pharmaceuticals (MDGL) Gets a Buy Rating from Oppenheimer
11:31pm, Wednesday, 15'th Apr 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Madrigal Pharmaceuticals (MDGL) today and set a price target of $200.00. The company's shares
Madrigal Pharmaceuticals (MDGL) Gets a Buy Rating from Oppenheimer
11:31pm, Wednesday, 15'th Apr 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a price
ACADIA Pharmaceuticals to Announce First Quarter 2020 Financial Results on May 7, 2020
08:05pm, Wednesday, 15'th Apr 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Thursday, May 7, 2020, after the clo
